COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 181 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $204,413 | -16.4% | 9,512 | -6.7% | 0.00% | 0.0% |
Q1 2023 | $244,650 | -90.2% | 10,198 | -90.5% | 0.00% | -91.2% |
Q4 2022 | $2,486,715 | +22.1% | 107,186 | -15.7% | 0.03% | +13.3% |
Q3 2022 | $2,037,000 | -8.5% | 127,140 | +1.2% | 0.03% | -6.2% |
Q2 2022 | $2,226,000 | -14.2% | 125,633 | -1.3% | 0.03% | 0.0% |
Q1 2022 | $2,593,000 | +10.3% | 127,345 | +1.2% | 0.03% | +10.3% |
Q4 2021 | $2,350,000 | -4.4% | 125,825 | +1.0% | 0.03% | -12.1% |
Q3 2021 | $2,459,000 | +14.6% | 124,582 | +37.3% | 0.03% | +10.0% |
Q2 2021 | $2,146,000 | -0.4% | 90,769 | -0.2% | 0.03% | -6.2% |
Q1 2021 | $2,155,000 | +26.0% | 90,941 | +6.5% | 0.03% | +14.3% |
Q4 2020 | $1,710,000 | -2.2% | 85,360 | +1.6% | 0.03% | -12.5% |
Q3 2020 | $1,749,000 | +74.7% | 84,010 | +46.9% | 0.03% | +60.0% |
Q2 2020 | $1,001,000 | – | 57,202 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |